Straub Medical has approved a full acquisition by Becton, Dickinson and Company (BD). The acquisition was completed on 20 April 2020. Straub Medical manufactures, develops, and sells medical devices for the treatment of arterial and venous diseases that are used worldwide by vascular surgeons and interventional specialists in radiology, angiology, and surgery.
Gido Karges, CEO of Straub Medical, comments: “BD is the ideal strategic addition to Straub Medical. With its complementary product portfolio and established global sales channels, BD offers treatment solutions for vascular specialists around the world to advance the world of health.”
“With our extensive expertise in endovascular technologies and our strong global infrastructure, BD is the right company to offer Straub Medical products worldwide as an important building block of our modern treatment solutions,” says Steve Williamson, president of BD’s Peripheral Intervention business. “We are committed to improving the quality of life for the more than 200 million people worldwide who are affected by occlusive diseases of the peripheral arteries. We are also committed to providing more instruments for treating venous diseases. The acquisition of Straub Medical makes it possible to help physicians worldwide treat even more affected patients.”
All employees in all branches are taken over by BD.